Increased ErbB3 and EGFR activity mediate lapatinib resistance in prostate cancer

被引：0
|
作者：
Jathal, Maitreyee K. [1 ]
Steele, Thomas M. [2 ]
Mooso, Benjamin A. [2 ]
D'Abronzo, Leandro S. [1 ]
Siddiqui, Salma [2 ]
Drake, Christiana [1 ]
Ghosh, Paramita M. [1 ]
机构：
[1] Univ Calif Davis, Davis, CA USA
[2] VA Med Ctr, Sacramento, CA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-3335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3335
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ErbB3 as a regulator of EGFR signaling
    Rush, J. S.
    Griffey, H.
    Ceresa, B. P.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [2] Expression and nuclear localization of ErbB3 in prostate cancer
    Koumakpayi, IH
    Diallo, JS
    Le Page, C
    Lessard, L
    Gleave, M
    Bégin, LR
    Mes-Masson, AM
    Saad, F
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2730 - 2737
  • [3] Role of erbB3 receptors in cancer therapeutic resistance
    Lee, Youngseok
    Ma, Jian
    Lyu, Hui
    Huang, Jingcao
    Kim, Aeree
    Liu, Bolin
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (03) : 190 - 198
  • [4] Amiloride sensitizes prostate cancer cells to the reversible tyrosine kinase inhibitor lapatinib by modulating Erbb3 subcellular localization
    Jathal, Maitreyee K.
    Mudryj, Maria
    Dall'Era, Marc A.
    Ghosh, Paramita M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 82 (01)
  • [5] MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer
    Zhang, Yuanzhou
    Liang, Shunshun
    Xiao, Bowen
    Hu, Jingying
    Pang, Yechun
    Liu, Yuling
    Yang, Juan
    Ao, Junpin
    Wei, Lin
    Luo, Xiaoying
    CELL DEATH & DISEASE, 2022, 13 (03)
  • [6] Mathematical modeling and analysis of ErbB3 and EGFR dimerization process for the gefitinib resistance
    Itano, Keiko
    Ito, Takeshi
    Kawasaki, Shuji
    Murakami, Yoshinori
    Suzuki, Takashi
    JSIAM LETTERS, 2018, 10 : 33 - 36
  • [7] MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer
    Yuanzhou Zhang
    Shunshun Liang
    Bowen Xiao
    Jingying Hu
    Yechun Pang
    Yuling Liu
    Juan Yang
    Junpin Ao
    Lin Wei
    Xiaoying Luo
    Cell Death & Disease, 13
  • [8] ERBB3 as predictor of response and target for overcoming resistance to EGFR inhibitors in NSCLC
    Witta, S
    Hirsch, F
    Coldren, C
    Helfrich, B
    Zeng, C
    Barón, A
    Bunn, P
    Varella-Garcia, M
    LUNG CANCER, 2005, 49 : S66 - S66
  • [9] Targeting of erbB3 receptor to overcome resistance in cancer treatment
    Jian Ma
    Hui Lyu
    Jingcao Huang
    Bolin Liu
    Molecular Cancer, 13
  • [10] Targeting of erbB3 receptor to overcome resistance in cancer treatment
    Ma, Jian
    Lyu, Hui
    Huang, Jingcao
    Liu, Bolin
    MOLECULAR CANCER, 2014, 13
12345